Possible side-effects uncovered in macular degeneration drug

A drug which should have great potential in helping to minimise the effects of the blinding condition macular degeneration may have some side-effects, according to one researcher in the US. Mayo Clinic scientist Dr Sophie Bakri has found that the Food and Drug Administration-approved ranibizumab (Lucentis) may be increasing pressure inside some patients" eyes.